Gamma delta T cell ligands (γδ T cell ligands)

Gamma delta T cell ligands represent a diverse group of cell-surface proteins that are upregulated in response to cellular stress, including malignant transformation, viral infection, and DNA damage. These ligands, such as MHC class I-related chains A and B (MICA/B), UL16-binding proteins (ULBPs), and butyrophilin family members (e.g., BTN3A1), act as critical 'danger signals' recognized by γδ T-cell receptors (TCRs) or activating co-receptors like NKG2D (Nature Reviews Immunology, 2019). Unlike conventional αβ T cells, γδ T cells recognize these ligands in an MHC-independent manner, enabling rapid and broad-spectrum immune surveillance against various tumors (Frontiers in Immunology, 2020). In oncology, these ligands are targeted to harness the potent cytotoxic potential of γδ T cells. Therapeutic agents such as the monoclonal antibody ICT01, which targets BTN3A, and various bispecific T-cell engagers are designed to activate or redirect γδ T cells toward tumor cells expressing these stress markers (Journal for ImmunoTherapy of Cancer, 2021). These approaches aim to exploit the natural ability of γδ T cells to infiltrate solid tumors and provide a safety advantage by sparing healthy, non-stressed tissues. However, challenges such as ligand shedding and immune evasion mechanisms in the tumor microenvironment remain significant hurdles for clinical efficacy.

Other names

Tumor- and stress-induced ligands recognized by γδ T cellsStress-induced ligandsNKG2D ligandsButyrophilinsMICA/BULBPsBTN3ABTN2A1

Activation of γδ T cells via direct binding to T-cell receptors (TCR) or activating co-receptors (e.g., NKG2D), leading to the release of cytotoxic granules (perforin/granzyme) and pro-inflammatory cytokines (IFN-γ, TNF-α) against stressed or malignant cells.